Nautilus Biotechnology Inc (NAUT) Actualités

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Nautilus Biotechnology Reports Third Quarter 2024 Financial Results

SEATTLE, Oct. 29, 2024 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a...

Nautilus Biotechnology to Announce Third Quarter 2024 Financial Results on October 29, 2024

SEATTLE, Oct. 08, 2024 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a...

Form 4 - Statement of changes in beneficial ownership of securities

Form 3 - Initial statement of beneficial ownership of securities

Nautilus Biotechnology Appoints Mass Spectrometry Leader Ken Suzuki as Chief Marketing Officer

SEATTLE, Sept. 17, 2024 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a...

Nautilus Biotechnology to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference

SEATTLE, Aug. 14, 2024 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a...

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Nautilus Biotechnology Reports Second Quarter 2024 Financial Results

SEATTLE, July 30, 2024 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a...

Nautilus Biotechnology to Announce Second Quarter 2024 Financial Results on July 30, 2024

SEATTLE, July 09, 2024 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a...

Form 4 - Statement of changes in beneficial ownership of securities

Form 8-K - Current report

Nautilus Biotechnology to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference

SEATTLE, May 23, 2024 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a...

Nautilus Biotechnology Reports First Quarter 2024 Financial Results

SEATTLE, April 30, 2024 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a...

Nautilus Biotechnology to Announce First Quarter 2024 Financial Results on April 30, 2024

SEATTLE, April 11, 2024 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a...